Oxford Nanopore Technologies Ltd (ONT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Oxford Nanopore Technologies Ltd (ONT) has a cash flow conversion efficiency ratio of -0.040x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-18.60 Million ≈ $-2.26K USD) by net assets (GBX463.30 Million ≈ $56.37K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ONT equity financing ratio to measure how much of total assets are equity-financed.
Oxford Nanopore Technologies Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Oxford Nanopore Technologies Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Oxford Nanopore Technologies Ltd (ONT) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Oxford Nanopore Technologies Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oxford Nanopore Technologies Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dantax
CO:DANT
|
-0.091x |
|
Vizione Holdings Bhd
KLSE:7070
|
-0.027x |
|
Rcm Beteiligungs AG
F:RCMN
|
N/A |
|
Obiz Concept SAS
PA:ALBIZ
|
0.430x |
|
ValOre Metals Corp
V:VO
|
-0.094x |
|
Impact Minerals Ltd
AU:IPT
|
-0.082x |
|
Airthings ASA
OL:AIRX
|
-0.177x |
|
Miwon Chemical
KO:134380
|
0.065x |
Annual Cash Flow Conversion Efficiency for Oxford Nanopore Technologies Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Oxford Nanopore Technologies Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Oxford Nanopore Technologies Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX463.30 Million ≈ $56.37K |
GBX-62.80 Million ≈ $-7.64K |
-0.136x | +27.67% |
| 2024-12-31 | GBX586.34 Million ≈ $71.34K |
GBX-109.89 Million ≈ $-13.37K |
-0.187x | +12.12% |
| 2023-12-31 | GBX643.85 Million ≈ $78.34K |
GBX-137.30 Million ≈ $-16.71K |
-0.213x | -199.47% |
| 2022-12-31 | GBX693.56 Million ≈ $84.39K |
GBX-49.39 Million ≈ $-6.01K |
-0.071x | +6.87% |
| 2021-12-31 | GBX703.98 Million ≈ $85.65K |
GBX-53.83 Million ≈ $-6.55K |
-0.076x | +77.72% |
| 2020-12-31 | GBX185.93 Million ≈ $22.62K |
GBX-63.81 Million ≈ $-7.76K |
-0.343x | +22.79% |
| 2019-12-31 | GBX109.53 Million ≈ $13.33K |
GBX-48.68 Million ≈ $-5.92K |
-0.444x | -14.41% |
| 2018-12-31 | GBX142.89 Million ≈ $17.39K |
GBX-55.51 Million ≈ $-6.75K |
-0.388x | +45.20% |
| 2017-12-31 | GBX93.58 Million ≈ $11.39K |
GBX-66.34 Million ≈ $-8.07K |
-0.709x | -101.08% |
| 2016-12-31 | GBX145.24 Million ≈ $17.67K |
GBX-51.21 Million ≈ $-6.23K |
-0.353x | -6.91% |
| 2015-12-31 | GBX100.48 Million ≈ $12.23K |
GBX-33.14 Million ≈ $-4.03K |
-0.330x | +35.73% |
| 2014-12-31 | GBX66.02 Million ≈ $8.03K |
GBX-33.88 Million ≈ $-4.12K |
-0.513x | -45.03% |
| 2013-12-31 | GBX65.77 Million ≈ $8.00K |
GBX-23.27 Million ≈ $-2.83K |
-0.354x | +16.95% |
| 2012-12-31 | GBX49.94 Million ≈ $6.08K |
GBX-21.27 Million ≈ $-2.59K |
-0.426x | -- |
About Oxford Nanopore Technologies Ltd
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version… Read more